These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15555998)

  • 1. A molecular switch created by in vitro recombination of nonhomologous genes.
    Guntas G; Mitchell SF; Ostermeier M
    Chem Biol; 2004 Nov; 11(11):1483-7. PubMed ID: 15555998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch.
    Kim JR; Ostermeier M
    Arch Biochem Biophys; 2006 Feb; 446(1):44-51. PubMed ID: 16384549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed evolution of protein switches and their application to the creation of ligand-binding proteins.
    Guntas G; Mansell TJ; Kim JR; Ostermeier M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11224-9. PubMed ID: 16061816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering switches, genetically.
    Roberts RW
    Chem Biol; 2004 Nov; 11(11):1475-6. PubMed ID: 15555994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR characterization of an engineered domain fusion between maltose binding protein and TEM1 beta-lactamase provides insight into its structure and allosteric mechanism.
    Wright CM; Majumdar A; Tolman JR; Ostermeier M
    Proteins; 2010 May; 78(6):1423-30. PubMed ID: 20034108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating molecular diversity by homologous recombination in Escherichia coli.
    Wang PL; Lo BK; Winter G
    Protein Eng Des Sel; 2005 Aug; 18(8):397-404. PubMed ID: 15983006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
    Heins RA; Choi JH; Sohka T; Ostermeier M
    PLoS One; 2011; 6(11):e27302. PubMed ID: 22096548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular protein switches derived from antibody mimetic proteins.
    Nicholes N; Date A; Beaujean P; Hauk P; Kanwar M; Ostermeier M
    Protein Eng Des Sel; 2016 Feb; 29(2):77-85. PubMed ID: 26637825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic protein switches built from paralogous input domains.
    Tullman J; Nicholes N; Dumont MR; Ribeiro LF; Ostermeier M
    Biotechnol Bioeng; 2016 Apr; 113(4):852-8. PubMed ID: 26461040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of an engineered β-lactamase maltose binding protein fusion protein: insights into heterotropic allosteric regulation.
    Ke W; Laurent AH; Armstrong MD; Chen Y; Smith WE; Liang J; Wright CM; Ostermeier M; van den Akker F
    PLoS One; 2012; 7(6):e39168. PubMed ID: 22720063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of a fusion protein to exhibit disulfide-mediated logic gate behavior.
    Choi JH; Ostermeier M
    ACS Synth Biol; 2015 Apr; 4(4):400-6. PubMed ID: 25144732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-allosteric enzyme switches possess larger effector-induced changes in thermodynamic stability than their non-switch analogs.
    Choi JH; San A; Ostermeier M
    Protein Sci; 2013 Apr; 22(4):475-85. PubMed ID: 23400970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 beta-lactamase to an amino acid deletion.
    Jones DD
    Nucleic Acids Res; 2005 May; 33(9):e80. PubMed ID: 15897323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between effector binding and allostery in an engineered protein switch.
    Choi JH; Xiong T; Ostermeier M
    Protein Sci; 2016 Sep; 25(9):1605-16. PubMed ID: 27272021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided SCHEMA recombination of distantly related beta-lactamases.
    Meyer MM; Hochrein L; Arnold FH
    Protein Eng Des Sel; 2006 Dec; 19(12):563-70. PubMed ID: 17090554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ArgR-dependent repression of arginine and histidine transport genes in Escherichia coli K-12.
    Caldara M; Minh PN; Bostoen S; Massant J; Charlier D
    J Mol Biol; 2007 Oct; 373(2):251-67. PubMed ID: 17850814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tying up the loose ends: circular permutation decreases the proteolytic susceptibility of recombinant proteins.
    Whitehead TA; Bergeron LM; Clark DS
    Protein Eng Des Sel; 2009 Oct; 22(10):607-13. PubMed ID: 19622546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France.
    Girlich D; Poirel L; Carattoli A; Kempf I; Lartigue MF; Bertini A; Nordmann P
    Appl Environ Microbiol; 2007 Jul; 73(14):4681-5. PubMed ID: 17513592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.